InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Monte Rosa Therapeutics, Inc.

GLUE Clue Score47
United States Fiscal year ends December CIK 0001826457 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

17
Insider
Date
Role
Action
Shares
Price
Amount
Chandra P. Leo
24 Mar 2025
Director
Buy
10,000
$5.84
$58.38K
Cormorant Asset Management, LP
28 Jun 2021
Former 10% Owner
Buy indirect
600,000
$19.00
$11.40M
Versant Venture Capital VI, L.P.
28 Jun 2021
10% owner
Buy indirect
157,895
$19.00
$3.00M
Bradley J PhD Bolzon
28 Jun 2021
Director
Buy indirect
157,895
$19.00
$3.00M
New Enterprise Associates 17, L.P.
28 Jun 2021
10% owner
Buy
1,050,000
$19.00
$19.95M
Forest Baskett
28 Jun 2021
10% owner
Buy indirect
1,050,000
$19.00
$19.95M
Ali Behbahani
28 Jun 2021
Director
Buy indirect
1,050,000
$19.00
$19.95M
Carmen Chang
28 Jun 2021
10% owner
Buy indirect
1,050,000
$19.00
$19.95M
Anthony A. Florence Jr.
28 Jun 2021
10% owner
Buy indirect
1,050,000
$19.00
$19.95M
Liza Landsman
28 Jun 2021
10% owner
Buy indirect
1,050,000
$19.00
$19.95M
Mohamad Makhzoumi
28 Jun 2021
10% owner
Buy indirect
1,050,000
$19.00
$19.95M
Joshua Makower
28 Jun 2021
10% owner
Buy indirect
1,050,000
$19.00
$19.95M
Edward T Mathers
28 Jun 2021
10% owner
Buy indirect
1,050,000
$19.00
$19.95M
Scott D Sandell
28 Jun 2021
10% owner
Buy indirect
1,050,000
$19.00
$19.95M
Peter W. Sonsini
28 Jun 2021
10% owner
Buy indirect
1,050,000
$19.00
$19.95M
Paul Edward Walker
28 Jun 2021
10% owner
Buy indirect
1,050,000
$19.00
$19.95M
Rick Yang
28 Jun 2021
10% owner
Buy indirect
1,050,000
$19.00
$19.95M
Show all 64 transactions →

What was left out

Form 4 filings counted 135
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 18
Sales at will 22
Transactions with no price 0
Shares from compensation/vesting 109,003,555
History held since 25 Jun 2021